South African case study sheds light on how vaccine manufacturing can be developed
Additional costs made it harder for local companies to break even and recover working capital
Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far
Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines
How drug companies are sidestepping the WHO’s technology transfer hub in Africa
The actions of BioNTech and Moderna will prolong the social and economic costs of the pandemic
Eskom CEO quits: Why finding a new head for South Africa’s struggling power utility won’t end the blackouts
The company produces produces 95% of the electricity used in the country